Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q1 2017 · 10-Q
Revenue$109.06M$109.06M−19.4% vs Q1 2016 Net Income$3.31M$3.31M+12.2% vs Q1 2016 EPS Diluted$0.12$0.12+9.1% vs Q1 2016 Gross Profit$20,116,000+11.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$9,969,000N/M Free Cash Flowderived$7,838,000N/M Margins · derivedGross margin18.4%+5.2 pt vs Q1 2016
Operating margin5.0%+2.1 pt vs Q1 2016
Net margin3.0%+0.9 pt vs Q1 2016
ended Aug 28, 2016 · filed Sep 29, 2016 · 32 d after period end